JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression

  • 0Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Gastroenterology +

|

May 22, 2014

|

May 22, 2014

View abstract on PubMed

Summary

This summary is machine-generated.

Immunoglobulin transcription factor 2 (ITF2) suppresses colorectal cancer by inhibiting the beta-catenin pathway. Loss of ITF2 promotes tumor growth and is linked to poorer patient outcomes.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Immunoglobulin transcription factor 2 (ITF2) has conflicting roles in cancer, with prior belief in promoting neoplastic transformation.
  • Recent findings suggest ITF2 may suppress colon carcinogenesis, necessitating further investigation.

Purpose Of The Study

  • To investigate the roles of ITF2 in colorectal cancer cell lines.
  • To determine the impact of ITF2 on tumor formation and growth in mice.
  • To correlate ITF2 expression with clinical outcomes in patients with colorectal cancer.

Main Methods

  • Quantified ITF2, beta-catenin, and c-Myc levels in human colorectal tumors via immunohistochemistry.
  • Analyzed ITF2's regulation of beta-catenin and T-cell factor (TCF) using molecular assays.
  • Assessed xenograft tumor growth in mice with altered ITF2 expression levels.
  • Correlated ITF2 expression with patient outcomes using colorectal carcinoma tissue arrays.

Main Results

  • ITF2 levels were decreased and c-Myc levels increased in carcinomas compared to adenomas.
  • ITF2 negatively regulated the beta-catenin-TCF4 complex and its target genes in colorectal cancer cell lines.
  • Overexpression of ITF2 reduced tumor cell proliferation and tumorigenic potential in mice.
  • Loss of ITF2 in tumors correlated with poor patient outcomes and shorter survival times.

Conclusions

  • ITF2 inhibits beta-catenin-TCF4 complex activation and target gene transcription in colorectal cancer.
  • Loss of ITF2 promotes colorectal cancer cell tumorigenicity and is associated with tumor progression.
  • Reduced ITF2 expression is a potential biomarker for adverse clinical outcomes in colorectal cancer patients.

Keywords:

Related Concept Videos

Cells and Secretions of the Pancreas 01:16

4.3K

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion 01:27

2.1K

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...

Cell Specific Gene Expression 01:58

16.2K

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

Insulin Secretory Vesicles 01:05

6.3K

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

Transducer Mechanism: Enzyme-Linked Receptors 01:27

3.8K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor tyrosine kinases:

Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...

The Endocrine System 01:29

1.2K

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...